Forecasting COVID-19 pandemic using optimal singular spectrum analysis.

阅读:7
作者:Kalantari, Mahdi
Coronavirus disease 2019 (COVID-19) is a pandemic that has affected all countries in the world. The aim of this study is to examine the potential advantages of Singular Spectrum Analysis (SSA) for forecasting the number of daily confirmed cases, deaths, and recoveries caused by COVID-19, which are the three main variables of interest. This paper contributes to the literature on forecasting COVID-19 pandemic in several ways. Firstly, an algorithm is proposed to calculate the optimal parameters of SSA including window length and the number of leading components. Secondly, the results of two forecasting approaches in the SSA, namely vector and recurrent forecasting, are compared to those from other commonly used time series forecasting techniques. These include Autoregressive Integrated Moving Average (ARIMA), Fractional ARIMA (ARFIMA), Exponential Smoothing, TBATS, and Neural Network Autoregression (NNAR). Thirdly, the best forecasting model is chosen based on the accuracy measure Root Mean Squared Error (RMSE), and it is applied to forecast 40 days ahead. These forecasts can help us to predict the future behaviour of this disease and make better decisions. The dataset of Center for Systems Science and Engineering (CSSE) at Johns Hopkins University is adopted to forecast the number of daily confirmed cases, deaths, and recoveries for top ten affected countries until October 29, 2020. The findings of this investigation show that no single model can provide the best model for any of the countries and forecasting horizons considered here. However, the SSA technique is found to be viable option for forecasting the number of daily confirmed cases, deaths, and recoveries caused by COVID-19 based on the number of times that it outperforms the competing models.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。